Paroxetine, a potent selective long-acting inhibitor of synaptosomal 5-HT uptake in mice
- 1 September 1982
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 55 (3) , 217-226
- https://doi.org/10.1007/bf01276577
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTPActa Neurologica Scandinavica, 1982
- Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipraminePsychopharmacology, 1980
- Paroxetine: Pharmacokinetics, Tolerance and Depletion of Blood 5‐HT in ManActa Pharmacologica et Toxicologica, 1979
- Potent depletion of 5HT from monkey whole bloob by a new 5HT uptake inhibitor, paroxetine (FG 7051)European Journal of Pharmacology, 1978
- Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitorsEuropean Journal of Pharmacology, 1978
- CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE OXIDASE INHIBITOR, AND CLONAZEPAMBrain, 1977
- Beneficial effects of serotonin precursors in postanoxic action myoclonusNeurology, 1976
- EFFECT OF VINBLASTINE AND COLCHICINE ON UPTAKE AND RELEASE OF PUTATIVE TRANSMITTERS BY SYNAPTOSOMES AND ON BRAIN ACTOMYOSIN‐LIKE PROTEINJournal of Neurochemistry, 1973
- THE EFFECT OF IPRONIAZID AND IMIPRAMINE ON THE BLOOD PLATELET 5‐HYDROXYTRYPTAMINE LEVEL IN MANBritish Journal of Pharmacology and Chemotherapy, 1960